NCT06327438

Brief Summary

To examine the efficacy of complex decongestive therapy (CDT), cryotherapy and kinesio taping (KT) in patients with post-mastectomy lymphedema

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

March 16, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 25, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 16, 2024

Completed
Last Updated

March 25, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

March 15, 2024

Last Update Submit

March 22, 2024

Conditions

Keywords

Complex Decongestive Therapy; Cryotherapy; Kinesio Taping; Lymphedema; Post-mastectomy

Outcome Measures

Primary Outcomes (2)

  • Arm girth measurement is measured by Circumferential measurements

    It is a valid and reliable method, its protocol was used throughout, with measures performed on both arms at the axilla, halfway from the axilla to the cubital fossa, cubital fossa, halfway from the cubital fossa to the wrist, and at the wrist.

    12 consecutive weeks

  • Pain severity is measured by VAS

    It consisted of a line, often 10 cm long (100 mm); its ends are generally labelled with verbal pain anchors (e.g., "no pain" and "pain as bad as it could be")

    12 consecutive weeks

Secondary Outcomes (2)

  • The QOL is measured by SF-36

    12 consecutive weeks

  • Range of motion (ROM) is measured by UG

    12 consecutive weeks

Study Arms (3)

Group (A)

EXPERIMENTAL

(n=20) received complex decongestive therapy only

Other: Complex decongestive therapy

Group (B)

EXPERIMENTAL

(n=20) received cryotherapy and complex decongestive therapy

Other: Complex decongestive therapyDevice: Cryotherapy

Group (C)

EXPERIMENTAL

(n=20) received kinesio taping and complex decongestive therapy

Other: Complex decongestive therapyOther: Kinesio taping

Interventions

1. Manual lymphatic drainage (MLD). 2. Compression bandage. 3. Exercises to enhance lymphatic drainage. 4. Skin care.

Group (A)Group (B)Group (C)

It is a mature and safe-to-use system that cools the air to -32°C. Steps of application included: 1) Apply oil or cream to moisture the skin before cryotherapy application; 2) Initialize the mini cryo-air equipment at level 6.

Group (B)

It is a new choice in the field of physical therapy. The material used for the KT and the original concept of the taping technique were introduced by Dr Kenso Kase in 1973.

Group (C)

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged between 40 to 60 years. They were grade 2 and 3 lymphedema. They had more than 2 cm difference at circumference measurement. They had unilateral arm lymphedema post-mastectomy. They had completed chemotherapy and radiotherapy.

You may not qualify if:

  • Skin infection. Current ischemia. Systemic edema due to impaired heart, kidney and liver function. Current metastases. Venous thrombosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ragaee Saeed Mahmoud

Giza, Faisal, Egypt

RECRUITING

Ragaee Saeed Mahmoud

Faisal, Giza Governorate, 002, Egypt

RECRUITING

MeSH Terms

Conditions

Breast NeoplasmsLymphedema

Interventions

Cryotherapy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesLymphatic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

March 15, 2024

First Posted

March 25, 2024

Study Start

March 16, 2024

Primary Completion

June 16, 2024

Study Completion

July 16, 2024

Last Updated

March 25, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Intervention

Locations